A Metabolism-Related Gene Prognostic Index for Prediction of Response to Immunotherapy in Lung Adenocarcinoma

Immunotherapy, such as immune checkpoint inhibitors (ICIs), is a validated strategy for treating lung adenocarcinoma (LUAD) patients. One of the main challenges in ICIs treatment is the lack of efficient biomarkers for predicting response or resistance. Metabolic reprogramming has been proven to rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Bo, Hu, Lanlin, Jiang, Tao, Li, Yunchang, Xu, Huasheng, Zhou, Hang, Lan, Mei, Xu, Ke, Yin, Jun, Su, Chunxia, Zhou, Caicun, Xu, Chuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602971/
https://www.ncbi.nlm.nih.gov/pubmed/36293001
http://dx.doi.org/10.3390/ijms232012143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602971/
https://www.ncbi.nlm.nih.gov/pubmed/36293001
http://dx.doi.org/10.3390/ijms232012143

Ejemplares similares